Cargando…
Parthenolide Inhibits STAT3 Signaling by Covalently Targeting Janus Kinases
Aberrant activations of the STAT3 (signal transducer and activator of transcription 3) signaling pathway are associated with cancer and inflammatory diseases. Three of the four Janus kinases, JAK1, JAK2, and Tyk2, are the major upstream kinases of STAT3 in responses to cytokine stimulations. Among t...
Autores principales: | Liu, Man, Xiao, Chengqian, Sun, Mingwei, Tan, Minjia, Hu, Lihong, Yu, Qiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6100543/ https://www.ncbi.nlm.nih.gov/pubmed/29921758 http://dx.doi.org/10.3390/molecules23061478 |
Ejemplares similares
-
Xanthatin inhibits STAT3 and NF‐κB signalling by covalently binding to JAK and IKK kinases
por: Liu, Man, et al.
Publicado: (2019) -
Parthenolide reveals an allosteric mode to inhibit the deISGylation activity of SARS-CoV‑2 papain-like protease: Parthenolide covalently inhibits papain-like protease
por: Zou, Zhihui, et al.
Publicado: (2022) -
Covalent Modification of Human Serum Albumin by the Natural Sesquiterpene Lactone Parthenolide
por: Plöger, Michael, et al.
Publicado: (2015) -
Eriocalyxin B Inhibits STAT3 Signaling by Covalently Targeting STAT3 and Blocking Phosphorylation and Activation of STAT3
por: Yu, Xiaokui, et al.
Publicado: (2015) -
Docking and Selectivity Studies of Covalently Bound Janus Kinase 3 Inhibitors
por: Zhong, Haizhen A., et al.
Publicado: (2023)